Historical Industrial Culture
Sanofi is the heir to a long industrial history that includes some of the major scientific advances of the nineteenth and twentieth centuries, and the reputations of major industrial laboratories in the development of chemistry, pharmacy and medicine.
Supported by this huge industrial culture, CEPiA markets pharmaceutical intermediates and APIs that come from the accumulated know-how of former legacy companies which have been part of our Sanofi history, such as Rhône-Poulenc Rorer (Phenothiazines in the 1950s), Hoechst (Insuline in the 1860s), Sanofi (Valproic acid in the 1970s), Roussel-Uclaf (Corticosteroids in the 1950s), Synthelabo (Zolpidem in the 1980s), Francopia (Opiates in the 1930s), Chinoin (Prostaglandins in the 1970s)…
CEPiA, like its predecessors, is driven by the need to innovate and create. Thanks to this strong historical industrial background, today we benefit from great expertise in various fields such as synthesis, fermentation, purification and cell culture.